阿尔特：2025年前三季度净利润约-1.51亿元

Group 1 - The core viewpoint of the article highlights the financial performance of Alite (SZ 300825), which reported a revenue of approximately 736 million yuan for the first three quarters of 2025, representing a year-on-year increase of 19.3% [1] - The net profit attributable to shareholders of the listed company showed a loss of approximately 151 million yuan, with basic earnings per share reflecting a loss of 0.3082 yuan [1] - As of the report date, Alite's market capitalization stands at 5.4 billion yuan [1] Group 2 - The article also mentions the broader context of the Chinese innovative drug market, noting that overseas licensing has generated sales of 80 billion US dollars this year [1] - A discussion with Lu Gang, a partner at Chuangdong Investment, indicates a hot secondary market for biomedicine, while the primary market is experiencing a cooling in fundraising [1]